Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, “Prediabetes,” Diabetes and Atherosclerosis
Authors:
- 19 January 2021
- journal article
- review article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 67 (1) , 26-41
Abstract
Fat accumulation in the pancreas associated with obesity and the metabolic syndrome (MetS) has been defined as “non-alcoholic fatty pancreas disease” (NAFPD). The aim of this review is to describe the association of NAFPD with obesity, MetS, type 2 diabetes mellitus (T2DM) and atherosclerosis and also increase awareness regarding NAFPD. Various methods are used for the detection and quantification of pancreatic fat accumulation that may play a significant role in the differences that have been observed in the prevalence of NAFPD. Endoscopic ultrasound provides detailed images of the pancreas and its use is expected to increase in the future. Obesity and MetS have been recognized as NAFPD risk factors. NAFPD is strongly associated with non-alcoholic fatty liver disease (NAFLD) and it seems that the presence of both may be related with aggravation of NAFLD. A role of NAFPD in the development of “prediabetes” and T2DM has also been suggested by most human studies. Accumulation of fat in pancreatic tissue possibly initiates a vicious cycle of beta-cell deterioration and further pancreatic fat accumulation. Additionally, some evidence indicates a correlation between NAFPD and atherosclerotic markers (e.g., carotid intima–media thickness). Weight loss and bariatric surgery decreases pancreatic triglyceride content but pharmacologic treatments for NAFPD have not been evaluated in specifically designed studies. Hence, NAFPD is a marker of local fat accumulation possibly associated with beta-cell function impairment, carbohydrate metabolism disorders and atherosclerosis.Keywords
This publication has 168 references indexed in Scilit:
- The Association between Nonalcoholic Fatty Pancreas Disease and DiabetesPLOS ONE, 2013
- Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic ApproachesNutrients, 2013
- Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case–control retrospective studyCardiovascular Diabetology, 2013
- Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional studyArchives of Medical Science, 2013
- Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic SyndromeAngiology, 2011
- Comparison of Fat–Water MRI and Single‐voxel MRS in the Assessment of Hepatic and Pancreatic Fat Fractions in HumansObesity, 2010
- Glucolipotoxicity of the pancreatic beta cellBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Maternal obesity programmes offspring development of non-alcoholic fatty pancreas diseaseBiochemical and Biophysical Research Communications, 2010
- Noninvasive Quantification of Pancreatic Fat in HumansThe Journal of Clinical Endocrinology & Metabolism, 2009
- Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type‐2 diabetesClinical Anatomy, 2007